Product Description

• Grade Standard: Medicine Grade
• Brand Name: SHIMEN
• Purity (%): 5%

• Product Name: Dextrose Injection 5% , Glucose Injection 5%, Dextrose infusion 5%, Glucose infusion 5%

  Product  Description  :A clear, colourless or almost colourless liquid, taste sweet.

  Strength:5g/100ml, 12.5g/250ml, 25g/500ml

  INN or Generic Name:Hydrous Dextrose
  Pharmaceutical Dosage Form:  injection

  Port:Any port (depends on requests)       Certificate:GMP
  Exporting Region:Areas which GMP is applicable

  Therapeutic indications
  Intravenous solutions containing Dextrose are indicated for parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient.

  Posology and method of administration

  The dose is dependent upon the age, weight and clinical condition of the patient.

  As reported in the literature, the dosage and constant infusion rate of intravenous Dextrose must be selected with caution in pediatric patients, particularly neonates and low birth weight infants, because of the increased risk of hyperglycemia/hypoglycemia.

  Drug Interactions

  Additives may be incompatible. Consult with pharmacist, if available. When introducing additives, use aseptic technique, mix thoroughly and do not store.

  Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. See PRECAUTIONS.

  Contraindications:

  5% Dextrose Injection, USP without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.

  Special warning and precautions for use:

  Warnings
  Excessive administration of potassium-free solutions may result in significant hypokalemia.
  The intravenous administration of these solutions can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema.
  The risk of dilutional states is inversely proportional to the electrolyte concentrations of administered parenteral solutions. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of such solutions.
  Precautions
  Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations and acid-base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.
  Solutions containing Dextrose should be used with caution in patients with known subclinical or overt diabetes mellitus.

  Do not administer unless solution is clear and container is undamaged. Discard unused portion.

  Carcinogenesis, Mutagenesis, Impairment of Fertility:
  Studies with 5% Dextrose Injection, USP have not been performed to evaluate carcinogenic potential, mutagenic potential or effects on fertility.

  Interaction with other medicinal products and other forms of Interactions

  
  None known

  Pregnancy and lactation

  Pregnancy:
  Teratogenic effects
  Pregnancy Category C. Animal reproduction studies have not been conducted with Dextrose. It is also not known whether Dextrose can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Dextrose should be given to a pregnant woman only if clearly needed.
  Nursing Mothers:
  Caution should be exercised when 5% Dextrose Injection, USP is administered to a nursing mother.
  Pediatric Use:
  The safety and effectiveness in the pediatric population are based on the similarity of the clinical conditions of the pediatric and adult populations. In neonates or very small infants the volume of fluid may affect fluid and electrolyte balance.
  Frequent monitoring of serum glucose concentrations is required when Dextrose is prescribed to pediatric patients, particularly neonates and low birth weight infants.
  In very low birth weight infants, excessive or rapid administration of Dextrose injection may result in increased serum osmolarity and possible intracerebral hemorrhage.
  Geriatric Use:
  An evaluation of current literature revealed no clinical experience identifying differences in response between elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy..
  Effects on ability to drive and use machine
  Not applicable.
  Undesirable effects
  Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia.
  If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.

  Overdose and special antidotes

  In the event of overhydration or solute overload, re-evaluate the patient and institute appropriate corrective measures. See WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS.

Company Profile

• Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
• [ China ]
• This company is registered as a free member and is not verified or authenticated by Tradekey.com
• We are writing for you to establish long-term trade relationship with you. Shijiazhuang No.4 Pharmaceutical Co., Ltd. was established in 1948. Now we are a large-sized civilian-run public share holding and comprehensive medicine manufacturer in China. Our capital is USD14 million, and we have more than 3000 employees. Our company can manufacture 7 series of medicines with more than 100 ...
  

Basic Information

• Company Products / Services: large volume injection, oral preparation¼Œglucose injection veterinary, sodium chloride injection, veterinary
• Year Established: 1948
• Number of Employees: 100+
• Website: http://www.sjzsiyao.com/